Comparative Efficacy of Umeclidinium Bromide Versus Other Long-Acting Anticholinergic Monotherapies as Treatments for Copd Patients

Value in Health- United Kingdom

doi 10.1016/j.jval.2014.08.2013

Full Text

Abstract

Available in

Date

November 1, 2014

Authors

A. Ismaila

E. Huisman

Y.S. Punekar

Publisher

Elsevier BV

Related search

Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients With COPD: Pooled Results of Randomized Placebo-Controlled Trials

Pulmonary Therapy

2016

English

NEW FIXED COMBINATION OF LONG-ACTING ANTICHOLINERGIC GLYCOPYRRONIUM BROMIDE AND Β2-Agonist OF INDACATEROL: PROSPECTS OF COBD THERAPY

Medical Council

2016

English

Efficacy of a New Once-Daily Long-Acting Inhaled 2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD

English

Additive Efficacy of Short-Acting Bronchodilators on Dynamic Hyperinflation and Exercise Tolerance in Stable COPD Patients Treated With Long-Acting Bronchodilators

English

Early Impact of Treatment With Tiotropium, Long-Acting Anticholinergic Preparation, In patients With COPD &Ndash; Real-Life Experience From an observational Study

International Journal of COPD

English

Comparative Efficacy of Long-Acting Β2-Agonists as Monotherapy for Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis

International Journal of COPD

English

Long-Acting Injectable Antipsychotics as Maintenance Treatments for Bipolar Disorder-A Critical Review of the Evidence

Bipolar Disorders

Psychiatry

Biological Psychiatry

Mental Health

2018

English

Systematic Review and Network Meta-Analysis of the Efficacy and Safety of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Comparison With Other Long-Acting Muscarinic Antagonist/Long-Acting Β2-Agonist Fixed-Dose Combinations in COPD

Therapeutic Advances in Respiratory Disease

English

Reduction in All-Cause Mortality With Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients

American Journal of Respiratory and Critical Care Medicine

Pulmonary

Critical Care

Respiratory Medicine

Intensive Care Medicine

2020

English

Amanote Research

Comparative Efficacy of Umeclidinium Bromide Versus Other Long-Acting Anticholinergic Monotherapies as Treatments for Copd Patients

Value in Health- United Kingdom

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients With COPD: Pooled Results of Randomized Placebo-Controlled Trials

NEW FIXED COMBINATION OF LONG-ACTING ANTICHOLINERGIC GLYCOPYRRONIUM BROMIDE AND Β2-Agonist OF INDACATEROL: PROSPECTS OF COBD THERAPY

Efficacy of a New Once-Daily Long-Acting Inhaled 2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD

Additive Efficacy of Short-Acting Bronchodilators on Dynamic Hyperinflation and Exercise Tolerance in Stable COPD Patients Treated With Long-Acting Bronchodilators

Early Impact of Treatment With Tiotropium, Long-Acting Anticholinergic Preparation, In patients With COPD &Ndash; Real-Life Experience From an observational Study

Comparative Efficacy of Long-Acting Β2-Agonists as Monotherapy for Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis

Long-Acting Injectable Antipsychotics as Maintenance Treatments for Bipolar Disorder-A Critical Review of the Evidence

Systematic Review and Network Meta-Analysis of the Efficacy and Safety of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Comparison With Other Long-Acting Muscarinic Antagonist/Long-Acting Β2-Agonist Fixed-Dose Combinations in COPD

Reduction in All-Cause Mortality With Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients

Amanote Research

Comparative Efficacy of Umeclidinium Bromide Versus Other Long-Acting Anticholinergic Monotherapies as Treatments for Copd Patients

Value in Health- United Kingdom

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients With COPD: Pooled Results of Randomized Placebo-Controlled Trials

NEW FIXED COMBINATION OF LONG-ACTING ANTICHOLINERGIC GLYCOPYRRONIUM BROMIDE AND Β2-Agonist OF INDACATEROL: PROSPECTS OF COBD THERAPY

Efficacy of a New Once-Daily Long-Acting Inhaled 2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD

Additive Efficacy of Short-Acting Bronchodilators on Dynamic Hyperinflation and Exercise Tolerance in Stable COPD Patients Treated With Long-Acting Bronchodilators

Early Impact of Treatment With Tiotropium, Long-Acting Anticholinergic Preparation, In&nbsp;patients With COPD &Ndash; Real-Life Experience From&nbsp;an&nbsp;observational Study

Comparative Efficacy of Long-Acting &Beta;2-Agonists as Monotherapy for Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis

Long-Acting Injectable Antipsychotics as Maintenance Treatments for Bipolar Disorder-A Critical Review of the Evidence

Systematic Review and Network Meta-Analysis of the Efficacy and Safety of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Comparison With Other Long-Acting Muscarinic Antagonist/Long-Acting Β2-Agonist Fixed-Dose Combinations in COPD

Reduction in All-Cause Mortality With Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients

Early Impact of Treatment With Tiotropium, Long-Acting Anticholinergic Preparation, In patients With COPD &Ndash; Real-Life Experience From an observational Study

Comparative Efficacy of Long-Acting Β2-Agonists as Monotherapy for Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis